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Abstract: Ca2+ is a universal signalling molecule involved in regulating cell cycle and fate, 
metabolism and structural integrity, motility and volume. Like other cells, red blood cells 
(RBCs) rely on Ca2+ dependent signalling during differentiation from precursor cells. 
Intracellular Ca2+ levels in the circulating human RBCs take part not only in controlling 
biophysical properties such as membrane composition, volume and rheological properties, 
but also physiological parameters such as metabolic activity, redox state and cell clearance. 
Extremely low basal permeability of the human RBC membrane to Ca2+ and a powerful 
Ca2+ pump maintains intracellular free Ca2+ levels between 30 and 60 nM, whereas blood 
plasma Ca2+ is approximately 1.8 mM. Thus, activation of Ca2+ uptake has an impressive 
impact on multiple processes in the cells rendering Ca2+ a master regulator in RBCs. 
Malfunction of Ca2+ transporters in human RBCs leads to excessive accumulation of Ca2+ 
within the cells. This is associated with a number of pathological states including sickle 
cell disease, thalassemia, phosphofructokinase deficiency and other forms of hereditary 
anaemia. Continuous progress in unravelling the molecular nature of Ca2+ transport 
pathways allows harnessing Ca2+ uptake, avoiding premature RBC clearance and 
thrombotic complications. This review summarizes our current knowledge of Ca2+ 
signalling in RBCs emphasizing the importance of this inorganic cation in RBC function 
and survival. 
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1. Introduction 
Ca2+ is a universal and ubiquitous signalling molecule [1,2], regulating cell cycle and fate, 
metabolism and structural integrity, motility and volume. Most of the Ca2+ in the cytosol is bound and 
buffered by numerous Ca2+ binding proteins, phospholipids and inorganic phosphate. When bound and 
buffered Ca2+ are included, total intracellular Ca2+ in red blood cells (RBCs) reaches 5.7 µM [3]. Basal 
free Ca2+ concentration in RBCs of healthy human beings under physiological conditions is estimated 
to be in the range of 30 to 60 nM [4]. A tremendous gradient of at least 40,000-fold between the 
cytosol and blood plasma where free Ca2+ concentration reaches up to 1.8 mM is maintained due to 
particularly low permeability of membranes to Ca2+ (~50 µmol/(lcells h)) and efficient extrusion of Ca2+ 
from the cells by the plasma membrane Ca2+ pump (PMCA) [4]. This gradient may be used for 
signalling purposes as opening of a few hundreds of channels transporting 106 ions per second over 
several milliseconds may result in >10-fold changes in free Ca2+ levels in the sub-membrane space, 
causing acute changes in the activity of multiple Ca2+ sensitive proteins involved in structural, 
signalling, metabolic and transport functions. Such a huge Ca2+ influx seems to exceed the RBC’s 
Ca2+-buffering abilities. Long-term increases in the Ca2+ permeability result in serious dysregulation of 
multiple cellular functions. The subsequent onset of proteolysis, oxidation, irreversible shrinkage and 
phosphatydylserine (PS) exposure to the extracellular membrane leaflet facilitate clearance of Ca2+ 
overloaded cells in case the latter have not been haemolysed when passing through capillaries. 
This review summarizes the current knowledge on the regulation of RBC Ca2+ levels, Ca2+ 
dependent processes and the potential role that Ca2+ might play in the development of RBC 
pathologies. For obvious reasons this review makes no claim to be complete, but wants to draw 
attention to open questions and mechanisms to be resolved in the field of Ca2+ signalling in RBCs. 
2. Ca2+ Transport across the RBC Membrane 
2.1. Ca2+ Extrusion Pathway: Plasma Membrane Ca2+ Pump  
It was realised very early on that the inhibition of the energy supply in RBCs leads to a Ca2+ 
increase [5]. Although the nature of the Ca2+ influx remained unknown for several decades, the 
extrusion mechanism was realized to be mediated by a plasma membrane Ca2+ pump (PMCA). For 
human RBC membrane the presence of the B-splice isoform of the PMCA1 was shown [6]. This  
P-type ATPase is ubiquitously expressed. It is composed of 1220 amino acids forming  
ten transmembrane domains, two intracellular loops containing ATP binding and phosphorylation sites 
and inward-facing N- and C-terminals. The latter contains a Ca2+ calmodulin binding domain, 
phosphorylation sites and a PDZ-binding domain serving as a docking terminal for a number of 
proteins [7]. The maximal Ca2+ extrusion rate in RBCs can vary within RBC populations of a single 
donor between >60 mmol/(lcells h) and <4 mmol/(lcells h) [8]. The maximal turnover rate of the PCMA 
is significantly higher in RBCs from light fractions compared to that in RBCs within dehydrated RBC 
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fractions following density centrifugation [9]. This reduction in Vmax in cells from the dense fraction 
was referred to as a hallmark of RBC senescence [10]. The maximal Ca2+ turnover rate of PMCA in 
the RBC membrane of healthy humans not loaded with Ca2+ is most likely never reached. The apparent 
Vmax for PMCA measured in such cells is ~50 μmol/(lcells h), the value equal to the passive Ca2+ uptake. 
The enzyme half-activation constant for Ca2+ was reported to be 4 μM, far above the actual free 
cytosolic Ca2+ levels in human RBCs [11]. 
Increases in the intracellular free Ca2+ are sensed by the PMCA and occur in response to the 
interaction of the Ca2+ calmodulin complex with the C-terminus of the enzyme. In Ca2+-loaded RBCs 
the limiting factor of the PMCA transport capacity is ATP availability. The pump is fuelled 
preferentially by a pre-membrane ATP pool [8,12,13] and has a Kd (ATP) of 145 μM [5,14]. Under 
conditions of permanent Ca2+ leak, activation of PMCA results in rapid ATP depletion. 
RBC-derived plasma membrane vesicles contain factors activating PMCA, such as arachidonic 
acid, ceramide and acidic phospholipids, whereas sphingosine suppresses its function [15–17]. The 
function of the PMCA is extremely temperature-sensitive with ~30-fold reduction in turnover rate for 
every 10 °C drop [18]. 
2.2. Ca2+ Influx Pathways 
Ca2+ influx through the plasma membrane of healthy human RBCs is extremely slow but increasing 
up-to 5-fold in cells of patients with sickle cell disease (SCD) and several other forms of hereditary 
haemolytic anaemia [4]. Several cation channels mediate inward movement of Ca2+. Significant 
progress in identification of ion channels in control of Ca2+ uptake has recently been reviewed [19]. 
Voltage-activated non-selective cation channels [20–22] were shown to be Ca2+ permeable [23]. 
These initial observations have all been performed on excised patches, but the presence of the channel 
was also shown in the whole cell configuration [24] and further flux-based characterisations have been 
performed [25–27]. However, a proof of the molecular identity remains to be provided. 
Furthermore, a P-type Ca2+ channel was pharmacologically identified [28] and shown to be a 
CaV2.1 channel by Western blot analysis [29]. This channel can be inhibited by ω-agatoxin TK [29]. 
However, in contrast to the initial investigations, in which activation by protein kinase C (PKC) was 
proposed, recent findings depicted a rather indirect interaction with PKC [30]. 
A recent report provided evidence for the presence of a transient receptor potential (TRP) channel 
of subtype C6 in the RBC membrane [31]. However, most of the work done so far was performed on 
murine RBCs and detailed characterization of this channel in human RBCs is missing. 
In addition, the expression of an NMDA receptor channel was initially reported for rat [32] and 
later in human RBCs using molecular biological and electrophysiological approaches [33]. NMDA 
receptor agonists include glutamate, N-methyl D-aspartate (NMDA), homocysteine, homocysteic acid, 
glycine and D-serine [34]. 
Recently, the protein PIEZO1 was reported as being mutated in RBCs in hereditary xerocytosis [35] 
without knowing its physiological function. However, PIEZO1 is characterized as a mechano-sensitive 
cation channel in heterologous expression systems [36,37]. 
Furthermore there is evidence for an AMPA receptor related channel activity in RBCs [38]. 
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All the channels mentioned above were reported to be present in human RBCs from healthy donors. 
However, some currents were only shown to be present in cells of patients. An example is an increase 
in non-selective cation conductance on RBC of SCD patients mediating or contributing to  
Psickle [39,40], an increased membrane permeability in SCD RBC. It is still not completely clear if this 
reflects an increased activity of one or more of the above mentioned channels or yet another 
conductance [40,41]. However, recent investigations provide evidence for the involvement of the 
NMDA receptor [42]. 
3. Ca2+-Sensitive Proteins in RBCs 
3.1. Onset of Ca2+-Inducible Events and Ca2+ Sensors in RBCs 
When in the cell, Ca2+ activates numerous Ca2+ dependent proteins. Each of them has its own 
activation threshold. Thus, gradual increase in Ca2+ levels is associated with gradual activation of 
various groups of Ca2+-sensitive proteins involved in physiological and pathophysiological processes 
in RBCs. In Figure 1 we compiled current knowledge about the activation ranges of some selected 
proteins. This list of Ca2+ sensitive proteins is by far not comprehensive and can hardly be covered 
within one review. Despite a large number of such proteins and diversity of their functions, only few of 
them are “true” Ca2+ sensors interacting directly with calcium ions [43]. One of such ubiquitous 
sensors highly abundant in RBCs is calmodulin. Calmodulins 1–4 (CaM) are 17 kDa proteins 
comprising two globular EF hand Ca2+ binding domains enriched with carboxyl and carbonyl groups 
(Asp, Glu and Thr) interconnected with a flexible linker (for details see, e.g., [44,45]). Upon 
interaction with Ca2+, CaM wraps around amphipathic regions of the protein compacting into a 
globular shape and pulling the interacting domains of the target out of lipophilic pockets or out of the 
membrane lipid bilayer moiety. In RBCs the proteins regulated by interaction with the Ca2+ calmodulin 
2 complex (Ca-CaM) include, e.g., elements of the cytoskeletal network, the Na+/H+ exchanger NHE1, 
PMCA and the endothelial NO synthase (eNOS). Cytoplasmic CaM becomes active when recruited to 
the plasma membrane where its action is often coupled to that of phosphatidylinositol 4,5-bisphosphate 
(PIP2) localised at the inner leaflet of the membrane. An example of such coupling is a competitive 
binding of both co-regulators to the intracellular domain of NHE1 (see Figure 2A). 
Another class of “true” Ca2+ sensors (~650 proteins included) contain Ca2+ binding C2 domains 
interacting with 2–3 Ca2+ [43,46]. In RBCs proteins with C2 domains include phospholipases, PKCα, 
phosphoinositide 3-kinase (PI3K) and many others. Binding of Ca2+ to the C2 domains, triggers 
translocation of these proteins to the specific areas within plasma membrane containing their  
substrates [46]. 
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Figure 1. Overview of concentration dependence of Ca2+ activated events in RBCs. The 
yellow column indicates the estimated range of RBCs’ resting free Ca2+ [4]. The gray/black 
bars indicate the activation of the proteins with the intensity of darkness related to the 
activation level (details see below). The red lines depict the half activation concentration. 
For orientation, the green line provides the in vivo kD for Fluo-4 [47], probably the most 
appropriate Ca2+ fluorophore to be used in RBCs [48]. The universal intermediate 
messenger calmodulin has a dissociation constant for Ca2+ of 920 nM [49], which can be 
shifted down to 100 nM (see main text), indicated by the red arrow. The Gardos channel 
has an open probability of EC50 of 4.7 µM with a Hill slope factor of approximately 1 [50]. 
Values were measured in excised patches at a membrane potential of 0 mV. The curve of 
the opening frequency is almost superimposable (EC50 of 4.3 µM) [50] keeping the values 
given in the figure valid also for whole cell and hence population based investigations. The 
values for half maximal activation of the scramblase were determined by different studies 
with varying methodologies and a slightly different result. Values varied between 
approximately 30 µM determined in liposomes [51] and 70 µM measured in RBC  
ghosts [52]. The flippase depicts almost full inhibition already at a Ca2+ concentration of 
400 nM [53]. µ-Calpain, a protein that cleaves cytoskeleton and membrane proteins depicts 
half activation at 40 µM Ca2+ [54] but can be activated and then shifting half-maximal 
activation down to 200 nM [55]. Transglutaminase mediating polymerisation of RBC 
membrane proteins in its native form has a dissociation constant for Ca2+ of 190 µM [56]. 
Adenosine monophosphate (AMP) deaminase is an enzyme that converts AMP into inosin 
monophosphate and is directly stimulated by Ca2+ at a half maximal concentration of  
50 µM free Ca2+ [57]. The binding of Ca2+ to the C2-domain of PKCα was determined in 
vitro to be 35 µM with a Hill coefficient of 0.9 [58]. Although the Ca2+ dependence of the 
membrane binding was measured to be an order of magnitude lower [58], the initial Ca2+ 
binding is the crucial step for PKCα activation and therefore the relevant number in  
this compilation. 
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Figure 2. Ca2+ and RBC cytoskeleton. (A) Ca2+ sensitive elements of the cytoskeleton: 
band 4.1 and adducin interact with the Ca2+-calmodulin (Ca-CaM) complex. Adducin binds 
to actin blocking elongation of the fast-growing (barbing) ends of actin filaments within 
junctional complexes (J). When interacting with the band 3 dimers anchoring the spectrin 
network to the membrane, J become a part of bigger multi-protein complexes known as 
4.1R-comples (4.1RC). Interaction with Ca-CaM down-regulates capping activity of 
adducin regulating thereby actin filament assembly [59]. Furthermore, adducin tetramers 
participate in docking of carbonic anhydrase II (CAII) to band 3 tetrames. NHE1 is 
activated as it joins CAII and thereby becomes associated with the ankyrin complex  
(AC) [60,61]. Band 4.1R is an interacting partner of a number of proteins. Those include 
spectrin and actin which bind to the 10 kDa domain of the band 4.1R protein; band 3 
protein, p55, and GPC docking to the FERM domain of it and NHE1 interacting with its  
C-terminal 24 kDa domain. Interaction of band 4.1R with Ca-CaM triggers the reduction of 
the affinity of this protein to all interacting partners. As a result, spectrin network 
interaction with the integral proteins becomes loose. Decrease in affinity of band 4.1R to 
the cytosolic domain of NHE1 favours its dissociation from 4.1R and interaction with 
phoshatidylinositol 4,5-phosphate (PIP2), thus causing NHE activation [62]. PIP2 also 
modulates interaction of band 4.1R with glycophorin C and band 3 protein [63];  
(B) Schematic representation of the FERM (4.1/ezrin/radixin/moesin) domain of band 4.1 
protein, indicating docking ports for interacting partners and Ca-CaM binding sites (for 
details see [64]). 
 
3.2. Ca2+-Dependent Phosphorylation 
Changes in phosphorylation are among the most important modulations of protein activity in RBCs. 
Among the kinases there is a group of Ca2+ activated protein kinases, the conventional protein kinase C 
(cPKC) [65]. Among cPKCs, only protein kinase Cα (PKCα) can be found in RBCs [66]. Upon Ca2+ 
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binding, PKCα translocates to the plasma membrane, where it phosphorylates its target proteins.  
The kinase domain of PKCs lacks specificity [67,68] and therefore numerous proteins can be 
phosphorylated. Reports include the PMCA [69], cytoskeletal proteins ([70,71] and see below), 
NADPH oxidase [72] and possibly further proteins [29,30,73] are affected. 
3.3. Ca2+ and RBC Cytoskeleton 
Opening of cation channels in response to mechanical stress and the presence of activators, such as 
amino acids, proinflammatory cytokines and others, result in local transient increase in Ca2+ levels in 
the vicinity of the plasma membrane. The latter, most likely serves as a signal to mediate rapid 
reversible changes in cytoskeletal flexibility. 
The calcium-calmodulin complex (Ca-CaM) plays a key role in regulation of cytoskeletal stability. 
Selected elements of the cytoskeletal architecture interacting with Ca-CaM are schematically shown in 
Figure 2 together with their interacting partners. Those include major components of the cytoskeletal 
network, protein 4.1R, and adducin. These proteins function as docking stations for spectrin and actin, 
band 3 protein, glycophorins protein 4.2 and p55 and form a complex known as ankyrin-based 
complex and junctional complex (Figure 2A) [74,75]. The junctional complex is formed by the three 
principal components of the skeletal network junctions (spectin, actin, and 4.1R, together with 
tropomyosin, tropomodulin, adducin, dematin, p55). When associated with transmembrane proteins, 
GPC, XK, Kell, Duffy, band 3, and Rh junction complex forms a multiprotein 4.1R-based  
complex [76]. 
It is shown in Figure 2A, that the band 4.1R protein is a key constituent of all three complexes. 
Upon interaction with Ca-CaM, affinity of the 4.1R protein to all the interacting partners decreases and 
the cytoskeletal structure including spectrin-actin-tropomyosin junctions and the spectrin-actomyosin 
web interaction with the transmembrane protein clusters becomes loose and unstable. Such, Ca-CaM 
induced dissociation of NHE1 from the ankyrin complexes and band 4.1R protein. This facilitates the 
interaction of NHE1 with PIP2 resulting in activation of this ion transporter and dysregulation of cell 
volume and cytosolic alkalosis [62,77]. 
The Ca2+ concentration required for half-activation of calmodulin is 100 nM [78]–920 nM [49], 
Figure 1, thus no significant dissociation of the membrane cytoskeleton is expected to occur under 
physiological concentration of intracellular free Ca2+ [79]. Phosphorylation of calmodulin at Ser-80 
and -84 affects its affinity to 4.1R reducing their binding [80]. 
Ca2+ dependent phosphorylation is a second mode of action of Ca2+ on cytoskeletal proteins. 
Phosphorylation of the 4.1R protein at serine 312 and serine 331 by PKC was reported [81]. These two 
phosphorylation sites are localised within a domain flanked by the spectrin- and actin binding domain 
and a domain containing the interaction sites for transmembrane proteins (Figure 2B). When 
phosphorylated the 4.1R-β-spectrin interaction appears to be weakened by ~30% [81]. As Ca2+ uptake 
is known to be triggered by mechanical deformations [82], controlled reversible loosening of 
cytoskeletal network in cells passing through capillaries is an advantage. Uncontrolled irreversible loss 
of cytoskeletal stability in RBCs of patients with haemolytic anaemia, in which Ca2+ is permanently 
upregulated, on the contrary compromises mechanical stability of the RBC membrane [83]. In RBCs 
of healthy humans the 4.1R protein is not phosphorylated [81]. One more target of PKC is α-adducin 
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which, upon phosphorylation at Ser-726 decreases its affinity to F-actin, as it was observed in SCD 
RBCs. After the loss of F-actin capping dissociation of spectrin from actin occurs [84], which results 
in RBC inability to change shape. 
In RBCs transaminase 2 responds to Ca2+ entry with a rapid release of its inhibitory GTP and 
activation resulting in formation of Nε (γ-glutaminyl)lysine cross-linking (Figure 1). As a result, in 
Ca2+ overloaded RBCs formation of numerous polymeric protein complexes such as  
Glut1-adducin-dematin adducts as well as cross-linked complexes of Band 3-ankyrin-spectrin and 
glycophorin C-band 4.1-p55 occurs [85]. This Ca2+ induced remodelling of the cytoskeletal structure 
and concomitant changes in cell shape and membrane plasticity are suggested to contribute to 
premature RBC clearance. 
3.4. Ca2+ and RBC Volume Regulation 
RBC volume regulation is a complex process with contributions of numerous molecular players 
including, e.g., band 3 protein [86]. A marked volume decrease is mediated by the so-called Gardos 
effect, which was among the first Ca2+ dependent processes recognized in RBCs [87]. The 
corresponding Gardos channel was the first channel measured by patch-clamp in RBCs [88,89]. This 
channel is a Ca2+ activated K+ channel and the Gardos effect represents the Ca2+ induced K+ loss of 
RBCs. The channel is characterized by a single channel conductance of approximately 20 pS [88], a 
selectivity of K+ to Na+ of about 15:1 [90] and an EC50 (Ca2+) of 4.7 µM, Figure 1 with a Hill-slope of 
approximately 1 [50]. Later, the molecular identity of the Gardos channel was shown to be the hSK4 
channel [91]. Functionally, the opening of the Gardos channel leads to a hyperpolarisation and a loss 
of K+, Cl− and water resulting in cell shrinkage. Although the physiological function of the Gardos 
channel is not completely elucidated, there are two complementary concepts: (i) Openings of RBC 
Ca2+ channels by platelet released substances [92,93] initialy trigger the consecutive activation of the 
Gardos channel. This Gardos channel mediated dehydration of the RBC fosters their contribution in 
clot formation as outlined below. (ii) Local membrane deformation of RBCs was shown to trigger a 
transient increase in Ca2+ permeability with secondary activation of the Gardos channels [82]. This was 
proposed to induce significant dehydration even during a brief deformation event in the 
microcirculation [82]. 
3.5. Ca2+ and Lipid Bilayer 
Scramblase is a protein responsible for bidirectional transmembrane movement of phospholipids [94] 
leading to the break-down of the originally asymmetrical distribution of phospholipids between the 
inner and outer membrane leaflet [95]. It is a passive transport, but Ca2+ activated [51,52]. Its Ca2+ 
sensitivity is mediated by an EF hand motif [96]. The scramblase activity is complemented by the 
flippase (aminophospholipid translocase) inhibition [97]. This protein actively builds up phospholipid 
asymmetry and such can be regarded as the opponent of the scramblase. As shown in Figure 1, flippase 
activity is almost completely suppressed by 400 nM Ca2+ [53]. 
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3.6. Ca2+ and Metabolism 
Numerous reports emphasize the possible role of the Ca-CaM system in regulation of activity of 
glycolytic enzymes including pyruvate kinase [98,99]. However, even more important is its pivotal 
role in assembling the glycolytic enzymes at the RBC membrane. Band 3 protein and its cytosolic 
domain was shown to serve as a docking station for multiple glycolytic enzymes [100]. Ca2+ in turn 
was suggested to promote band 3 tyrosine phosphorylation [101]. Phosphorylation of the cytosolic 
domain of band 3 protein (cdb3) at Tyr9 and Tyr21 results in displacement of LDH, PK, GAPDH, 
PFK and aldolase from RBC membrane in intact cells [102]. A similar effect is induced by interaction 
of deoxyHb with band 3 protein [103]. 
3.7. Ca2+ and Redox State Preservation 
In RBCs there is a direct link between the intracellular free Ca2+ concentration and the haemoglobin 
oxygen saturation. In cells of healthy individuals, passive Ca2+ uptake was unaffected by 
deoxygenation, but the Vmax of the PMCA was reduced by 18%–32% [104]. This is not the case in 
RBCs of patients with SCD [4]. An increase in free Ca2+ levels was mainly attributed to changes in 
haemoglobin protonation, increases in protonation of deoxyhaemoglobin and a shift in the intracellular 
pH towards more alkaline values [104,105]. Along with augmentation of 2,3-diphosphoglycerate and 
ATP binding to haemoglobin, interaction of deoxyhaemoglobin with protons is associated with a 
decrease in Ca2+ buffering capacity of haemoglobin. In the cytosol of deoxygenated RBCs release of 
Ca2+ ions from protein binding sites and lowering of extrusion capacity of the PMCA contribute to 
both an increase in the ionised Ca2+ fraction by 34%–74% even in the absence of Ca2+ influx from the 
extracellular medium [104]. 
Increases in the free Ca2+ were recently linked to a lower oxygen affinity of haemoglobin promoting 
the release of oxygen [33]. Deoxygenation induced transient release of Ca2+ from intracellular buffers 
may promote further deoxygenation enhancing O2 dissociation from haemoglobin. Molecular 
mechanisms of this phenomenon remain to be investigated. 
Aside to the control of haemoglobin oxygenation, Ca2+ is also involved in the regulation of the 
RBC’s redox state. Ca-CaM complexes are co-activators of endothelial NO synthase (eNOS)  
activity [106,107]. Recently eNOS was shown to be present in circulating RBCs [108,109] and is 
activated by Ca2+ uptake during shear stress [82,110]. Nitric oxide is a scavenger of superoxide anions, 
which interacts with them two orders of magnitude faster than superoxide dismutase (SOD) [111]. 
However, following shortage of tetrahydrobiopterin or L-arginine eNOS itself gets uncoupled and is 
capable of generating superoxide anions, which is turned into H2O2 in a reaction catalysed by  
SOD [106]. Pro-oxidative action of uncoupled eNOS was demonstrated in RBCs [112]. 
3.8. Calpain and Its Targets in RBCs 
While the Ca2+ dependent cysteine protease µ-calpain (calpain-1) was mainly detected in human 
RBCs, m-calpain (calpain-2) was found to be virtually absent [113]. µ-Calpain is highly sensitive to 
Ca2+ with a half-activation concentration in the range of 3–50 µM [114,115]. The enzyme isolated 
from human RBCs displayed a value of 40 µM [54]. This is well above the free Ca2+ concentration 
Int. J. Mol. Sci. 2013, 14 9857 
 
 
found in both human RBCs from healthy individuals (30–60 nM) and values of 100–300 nM reported 
in RBCs from patients with hereditary forms of anaemia [4]. However, a 40 kDa activator protein 
which makes µ-calpain more Ca2+ sensitive, shifts Ca2+ concentrations required for half-maximal 
activation from 40–50 µM down to 0.2 µM [55]. In human RBCs a fraction of membrane-associated 
active µ-calpain was detected [116,117]. Activation mediated recruitment of calpain to the  
membrane [118] was used to estimate the protease activity revealing that ~7% of the calpain pool is 
constitutively active in RBCs from healthy individuals [117]. Consequently, the µ-calpain activity in 
RBCs from patients with hereditary anaemia forms was also increased because their resting Ca2+ levels 
were raised when compared to those from healthy donors. [4]. 
Targets of activated calpain are mainly transmembrane or membrane-associated proteins including 
PMCA, and bands 1, 2, 2.1, 3, 4.1, 4.2 proteins, but also calpain itself [119]. Autolysis occurs at Ca2+ 
levels beyond physiological concentrations, namely in the range 50–150 µM [114]. Limited digestion 
of haemoglobin α and β chains by calpain was also reported [120]. 
Recently, RBCs of a μ-calpain knock-out (KO) mouse displayed an improved deformability [121]. 
Furthermore it was demonstrated that ankyrin, band 3, band 4.1R, adducin and dematin were degraded 
in the Ca2+ loaded normal RBCs but not in the KO RBCs [121]. 
Cleavage of the PMCA by µ-calpain was associated with an activation of the pump, rapid ATP 
depletion, inactivation of the pump and gradual loss of the transmembrane Ca2+ gradients [122]. 
Calpastatin, an endogenous inhibitor of μ-calpain, is a natural regulator of the enzyme activity in 
RBCs. Both major and minor components of calpastatin, calpastatin H and L were detected in human 
RBCs [54]. Interaction of calpastatin with calpain is also Ca2+ sensitive. Half-maximal activation of 
calpastatin occurs at 40 µM Ca2+ [114], in bovine skeletal muscle derived enzyme. Activity of calpain 
and a decrease in calpastatin levels in RBCs was shown to occur in elderly humans [123,124]. 
3.9. Ca2+ and Inter-Cellular Interactions 
Due to the protein activity and lipid remodelling described above one would expect changes in 
rheological properties of RBC suspensions and indeed in numerous studies provoking increased 
cytosolic Ca2+ levels, an altered rheology was observed [125–127]. These changes were majorly 
explained by altered RBC deformability [128,129]. However, a second possibility to explain changes 
in rheological properties of RBC suspensions is RBC aggregation. 
A participation of RBC Ca2+ channels in blood clot formation was proposed previously [92,93] 
following earlier work already suggesting an active participation of RBCs in blood clot  
formation [130–132]. Further support was given by investigations showing Ca2+ mediated aggregation 
of RBCs [133–136] and RBC adhesion to the endothelium [137–139]. Further investigations are 
necessary to specify the required and sufficient conditions for such processes, e.g., the threshold of the 
intracellular Ca2+ concentration at which aggregation occurs. Additionally the modulations of the 
aggregation properties under in vivo conditions need to be elucidated. 
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4. The Physiological Role of Intracellular Ca2+: From RBC Birth to Clearance 
4.1. Ca2+ in RBC Haematopoiesis 
Ca2+ uptake is of key importance for promoting differentiation and proliferation of erythroid 
precursors at the stages of burst-forming units erythroid (BFU-E) colony-forming units erythroid 
(CFU-E) [140,141]. Increase in the intracellular Ca2+ is an integral part of the signalling pathway 
activated by binding of erythropoietin to its receptor [142,143]. In Ca2+-free medium, Ca2+ uptake is 
absent and differentiation and survival of erythroid precursors is compromised [140,141]. Inhibition of 
Ca2+ uptake by erythroid precursor cells cultured from mononuclear cells by the NMDA  
receptor antagonist MK-801 resulted in 45.5% ± 12.8% mortality of cells at the stage of basophilic  
and polychromatic erythroblasts suggesting that these receptors are actively contributing to 
erythropoiesis [33]. Additional evidence indicating that Ca2+ levels in reticulocytes are higher than in 
mature RBCs comes from secondary Ca2+-dependent processes such as phosphorylation [144]. Protein 
4.1R phosphorylation by PKC appeared to be markedly elevated in reticulocytes resulting in weakened 
interaction between β-spectrin and actin [145]. 
4.2. Ca2+ in Relation to the Physiological Function of RBCs 
For a long time, the physiological function of Ca2+ in mature RBCs was obscure and was believed 
to be limited to the involvement in RBCs aging and clearance [10,146,147]. However, a prominent part 
of this report reviews the physiological functions of Ca2+ in RBC regulating a broad range of processes 
including O2 transport [33], rheology [148], clotting [135,136] and half-life of cells (see Section 4.3). 
Each of these functions is vital for the organism. Thus, aberrant Ca2+ homeostasis in RBCs results in 
development of severe life-threatening systemic pathologies. 
Very recently, additional evidence in favour of a physiologically important Ca2+ associated 
mechanism was reported. Here, rises in the intracellular Ca2+ appear to promote the ability of RBCs to 
deliver oxygen [33]. 
4.3. Ca2+ in RBC Clearance 
At present it is suggested that in senescent RBCs the intracellular Ca2+ levels exceed those in 
reticulocytes and young RBCs [149]. However, such conclusions on the relationship between cell age 
and steady-state Ca2+ levels largely depend on the age markers employed. Typical age markers include 
glycosylated haemoglobin HbA1c, band 4.1a/b ratio, cell density, de-sialation and changes in CD47 
abundance at the membrane surface, PS exposure, and several others [149–151]. 
Activity of the PMCA in RBCs was shown to decrease with progressing HbA1c  
accumulation [152]. However, based on the pump-leak theory, this process will result in Ca2+ 
accumulation only when coupled to the unchanged or increasing activity in Ca2+-transporting ion 
channels. However, according to recent findings, this is not necessarily the case. Young rat and human 
RBCs contain higher number of NMDA receptors, that upon stimulation with plasma glycine and 
glutamate can cause significant Ca2+ influx [32,33]. Young cells are preferentially removed in subjects 
with induced or chronic polycytemia, phenomenon known as neocytolysis [112,153–155]. Finally, 
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phosphatydylserine (PS) exposure does not always correlate with high Ca2+ levels [156]. Thus, both 
young and senescent RBCs appear to be prone to Ca2+ overload, which may well trigger RBC 
clearance, but the relation of this mechanism to other Ca2+ independent clearance mechanisms and to 
in vivo relevance is still obscure. 
5. Ca2+ Dysbalance and Haemolytic Anaemia 
Independent of its origin, hereditary haemolytic anaemia is often associated with an increase in the 
intracellular Ca2+ levels [4]. “Leakiness” of RBC plasma membrane for Ca2+ that could not be 
compensated for by the activation of PMCA was reported for patients with SCD [157–159],  
beta-thalassemia (although most of the Ca2+ seem to be sequestered in vesicles or bound to cytosolic 
proteins) [160–162], phosphofructokinase deficiency [163]. Most of the information on Ca2+ transport 
in diseased RBCs was so far obtained for SCD patients. In these cells relatively high rates of Ca2+ 
uptake in RBCs are partially compensated for by sequestration of Ca2+ into intracellular inside-out 
vesicles, in which Ca2+ is pumped actively by PMCA [164]. Apparently, this process also exists in 
RBCs of patients with β-thalalssemia intermedia [162,165]. Furthermore, part of Ca2+ taken into the cells 
is immobilised by the intracellular proteins. Sickle cell transformation associated with polymerisation 
of deoxygenated mutated S-haemoglobin is amplified by 20–40-fold by dehydration [166]. Deoxygenation 
promotes Ca2+ uptake and release of ionised Ca2+ from the intracellular proteins (reduction in buffering 
capacity) [104,105,167]. In deoxygenated SCD RBC, an acute increase in the intracellular free Ca2+ 
RBCs causes opening of the Ca2+ sensitive Gardos channel and anion channels [168–170]. 
Downstream events triggered by augmentation of free intracellular Ca2+ comprise activation of  
µ-calpain [171] and activation of tyrosine phosphorylation [172]. In RBCs from SCD patients, protein 
4.1R and p55 appear to be phosphorylated thus contributing to the weakened interaction with  
beta-spectrin [84]. 
Cross-linked polymers have been observed in RBCs of patients with SCD suggesting 
hyperactivation of transglutaminase [85]. 
Oxidation of membrane proteins and impaired NO production by eNOS [173,174], increase in 
intercellular and RBC-endothelial adhesion [175] are hallmarks of SCD. Cross-linking of the nature of 
carrier of sickle cell conductance (Psickle) mediating Ca2+ uptake by RBCs remains unknown (compare 
Section 2.2). 
6. RBC Ca2+ Content and Medicinal Side Effects 
6.1. Transfusion Medicine 
Ca2+ overload is involved in dramatic reduction of the life span of stored RBCs used for  
transfusion [176]. Storage of leuco-depleted RBC concentrates is currently performed in Ca2+ free 
glucose-containing preservation citrate buffers at low temperatures. These storage conditions favour 
Ca2+ depletion of the cytosol, oxidative stress and ATP deprivation [177,178]. These processes induce 
deactivation of PMCA, facilitate passive Ca2+ transport and evoke acute Ca2+ overload when  
re-exposed to the plasma of patients receiving transfusions. The resulting processes include 
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dehydration, rigidity, fragmentation of cytoskeletal proteins and oxidative stress and increased 
adherence of RBCs to the endothelium and to each other [179,180]. 
6.2. Therapeutic Side Effects 
Additionally, unwanted modulations of the Ca2+ entry into RBC may cause side effects of drugs 
involved in therapies unrelated to RBCs. An example is photodynamic therapy, where the oxidative 
stress produced by the photosensitizer leads to the activation of cation channels in the RBC membrane 
and the consecutive Ca2+ entry triggers the mechanism described above, which is the major cause of an 
increased formation of blood aggregates as well as haemolysis [181]. Thus, RBC remain to be model cells 
to develop pharmacological strategies [182] and can even be used in automated safety screens [183]. 
7. Conclusion and Perspective 
The role of Ca2+ in RBCs physiology and pathophysiology cannot be overestimated. Many links 
between Ca2+ and RBC related diseases still need to be explored [184]. Methodologically single cell 
based methods will increase in their importance and contribution and complement cell population 
measurements [185]. This is due to the recent hindsight that intercellular heterogeneity and, in some 
cases, inhomogeneous distribution of Ca2+ within the cytosol are essential to predict the onset of 
changes related to the abnormally high Ca2+ levels, which are particularly important in patients with 
haematological disorders [42,186]. However, the properties of Ca2+ binding entities within the cells 
will need further attention and research. Following the broad variety of Ca2+ mediated processes 
mentioned here, monitoring the following parameters may be used to indirectly predict abnormally 
increased intracellular free Ca2+ levels in RBCs: (i) changes in cell volume and morphology 
(microcytosis, high MCHC, increase in cell density, echinocytosis or stomatocytosis); (ii) congenital 
haemolytic anaemia associated with stomatocytosis, reticulocytosis, and shortened RBC survival; 
(iii) decrease in the intracellular K+ levels, pseudohyperkalemia; (iv) loss of RBC deformability, 
changes in osmotic resistance, an increase when dehydration has occurred but cytoskeletal stability is 
still maintained, or a decrease when cytoskeleton is partially disassembled; (v) appearance of  
calpain-induced band 3 cleavage fragments; (vi) oxidative stress or unusually high NO production 
(nitrosated Hb, met-Hb); (vii) ATP depletion due to hyperactivation of PMCA; (viii) increase in  
inter-RBC aggregability; and (ix) increase in PS exposure. 
For many years the RBC was the cell of choice for membrane transport investigations. In the age of 
genomics, interest in RBC research decreased, but numerous signalling cascades—also in respect to 
the second messenger Ca2+ that occur in other cells and may involve several organelles—have been 
rediscovered in a modified and/or simplified form in RBCs. 
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